Kazuhisa Z. Takahashi
Experienced in Poland Syndrome

Kazuhisa Z. Takahashi

Tokyo, JP 
Experienced in Poland Syndrome
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Kazuhisa Takahashi practices in Tokyo, Japan. Takahashi is rated as an Experienced expert by MediFind in the treatment of Poland Syndrome. Their top areas of expertise are Lymphangioleiomyomatosis, Lung Cancer, Birt-Hogg-Dube Syndrome, Spinal Fusion, and Osteotomy.

Their clinical research consists of co-authoring 858 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Poland Syndrome.

Locations

Tokyo, Japan
Other Locations
Bunkyo, Japan
Hongo, 1138421, Japan
Kashiwa, Japan
Kitano, Japan
Japan
Hirakata, Japan
Osaka, Japan
Okazaki, Japan
Tsukuba, 3058568, Japan
Kyoto, Japan
Tottori, Japan
Nankoku, 7838509, Japan
Itabashi, 1740051, Japan
Akita, Japan
Chiba, Japan
Hirosaki, Japan
Anjo, Japan
Yokohama, Japan
Nagaoka, 9402188, Japan
Kawasaki, 2120013, Japan
Sendai, 9808578, Japan
Chuo, 2600856, Japan
Chuo, 2608670, Japan
Nagoya, Japan
Koshigaya, Japan
Nagasaki, Japan
Koshi, Japan
Suita, 5650871, Japan
Niigata, Japan
Asahi, 5458585, Japan
Sugimoto, 5588585, Japan
Otsu, Japan
Izunokuni, 4102295, Japan
Shimonagakubo, 4118777, Japan
Maebashi, Japan
Sagamihara, Japan
Kanagawa, Japan
Toyama, Japan
Hiroshima, Japan
Matsudo, Japan
Meguro, 1538902, Japan
Kanazawa, 9201192, Japan
Toshima, 1718501, Japan
Tochigi, Japan
Murakami, 2608670, Japan
Nigata-honmachi, Japan
Senboku, Japan
Maizuru Fisheries Research Station, Nagahama, Maizuru, 6250086, Japan
Shimotsuke, Japan
Naka, 3110193, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: February 09, 2026
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 3

858 Total Publications

Pneumocystis jirovecii pneumonia in a human caused by long-term use of veterinary drug oclacitinib: A case report.
Pneumocystis jirovecii pneumonia in a human caused by long-term use of veterinary drug oclacitinib: A case report.
Journal: IDCases
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Takahashi's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 14 Distinguished Conditions
View All 36 Advanced Conditions
View All 156 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile